Kathryn Moore

7PUBLICATIONS
47CO-AUTHORS
Innate immunityGenetic immunologyDevelopmental genetics (incl. sex determination)Predictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 27, 2026
IgG3 Hinge Architecture Expands Dengue Virus Breadth of A Quaternary Epitope Dependent Zika Virus Cross-Neutralizing Antibody.

Sanjeev Kumar, Connor A P Scott, Lingling Xu

|Aug 30, 2024
Eosinophils protect against SARS-CoV-2 following a vaccine breakthrough infection.

Kathryn M Moore, Stephanie L Foster, Meenakshi Kar

|Apr 03, 2024
Single-cell analysis reveals an antiviral network that controls Zika virus infection in human dendritic cells.

Kathryn M Moore, Adam-Nicolas Pelletier, Stacey Lapp

|Jan 31, 2024
Single cell analysis reveals an antiviral network that controls Zika virus infection in human dendritic cells.

Kathryn M Moore, Adam-Nicolas Pelletier, Stacey Lapp

|Jun 27, 2022
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant.

Rajesh M Valanparambil, Jennifer Carlisle, Susanne L Linderman

|Jan 04, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant.

Venkata-Viswanadh Edara, Kelly E Manning, Madison Ellis

Pageof 2